U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1865A>C (p.Asp622Ala) AND Hypercholesterolemia, familial, 1

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Feb 23, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000238393.2

Allele description [Variation Report for NM_000527.5(LDLR):c.1865A>C (p.Asp622Ala)]

NM_000527.5(LDLR):c.1865A>C (p.Asp622Ala)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1865A>C (p.Asp622Ala)
HGVS:
  • NC_000019.10:g.11120111A>C
  • NG_009060.1:g.35731A>C
  • NM_000527.5:c.1865A>CMANE SELECT
  • NM_001195798.2:c.1865A>C
  • NM_001195799.2:c.1742A>C
  • NM_001195800.2:c.1361A>C
  • NM_001195803.2:c.1484A>C
  • NP_000518.1:p.Asp622Ala
  • NP_001182727.1:p.Asp622Ala
  • NP_001182728.1:p.Asp581Ala
  • NP_001182729.1:p.Asp454Ala
  • NP_001182732.1:p.Asp495Ala
  • LRG_274:g.35731A>C
  • NC_000019.9:g.11230787A>C
  • c.1865A>C
Protein change:
D454A
Links:
LDLR-LOVD, British Heart Foundation: LDLR_001154; dbSNP: rs879255060
NCBI 1000 Genomes Browser:
rs879255060
Molecular consequence:
  • NM_000527.5:c.1865A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1865A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1742A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.1361A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.1484A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000295726LDLR-LOVD, British Heart Foundation
criteria provided, single submitter

(ACGS Guidelines, 2013)
Likely pathogenic
(Mar 25, 2016)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV0038413423billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Feb 23, 2023)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedliterature only
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate.

Graham CA, McIlhatton BP, Kirk CW, Beattie ED, Lyttle K, Hart P, Neely RD, Young IS, Nicholls DP.

Atherosclerosis. 2005 Oct;182(2):331-40.

PubMed [citation]
PMID:
16159606

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From LDLR-LOVD, British Heart Foundation, SCV000295726.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From 3billion, SCV003841342.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.96; 3Cnet: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with LDLR related disorder (ClinVar ID: VCV000252093 / PMID: 16159606). However, the evidence of pathogenicity is insufficient at this time. A different missense change at the same codon (p.Asp622Asn) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000252092). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 5, 2023